Filter
373
Text search:
pharmacology
Featured
Recommendations
34
New Publications
79
Language
Document type
No document type
192
Studies & Reports
73
Guidelines
68
Manuals
17
Training Material
7
Situation Updates
4
Fact sheets
4
Strategic & Response Plan
3
Resource Platforms
2
Online Courses
2
Brochures
1
Countries / Regions
India
32
South Africa
14
Ethiopia
10
Global
9
Africa
8
Nigeria
7
Nepal
6
Kenya
5
Rwanda
5
Bangladesh
5
Western and Central Europe
5
Russia
5
Uganda
4
Syria
4
Brazil
4
Latin America and the Carribbean
4
Sierra Leone
3
Ghana
3
Mozambique
3
Namibia
3
Eswatini/ Swaziland
3
Ukraine
3
Angola
3
Lesotho
3
Myanmar / Burma
3
Burkina Faso
2
Liberia
2
Congo, Democratic Republic of
2
Guinea-Bissau
2
USA
2
Zimbabwe
2
Germany
2
Zambia
2
Tanzania
2
Indonesia
2
Malawi
2
Argentina
2
Botswana
2
Eastern Europe
2
Haiti
1
Philippines
1
South Sudan
1
Iraq
1
Thailand
1
China
1
Sudan
1
Ecuador
1
Bolivia
1
East and Southern Africa
1
Paraguay
1
Asia
1
Mongolia
1
Southern Africa
1
Canada
1
Tajikistan
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
126
Clinical Guidelines
42
Public Health
17
Women & Child Health
8
Pharmacy & Technologies
7
Capacity Building
3
Key Resources
1
Toolboxes
Pharmacy
51
Mental Health
45
AMR
33
TB
25
HIV
24
COVID-19
21
Caregiver
12
NTDs
12
NCDs
12
Conflict
7
Specific Hazards
5
Ebola
4
Disability
3
Planetary Health
3
Natural Hazards
2
List of essential medicines for the management of patients admitted in intensive care units with a suspected or confirmed diagnosis of COVID 19. Third version, 1 February 2022
Updated Guidelines
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o
...
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
Lancet Infect Dis 2022 Published Online April 8, 2022 https://doi.org/10.1016/S1473-3099(22)00225-
Best Practices Report.PART 1 Primary Protection: Enhancing Health Care Resilience for a Changing Climatei Primary Protection: EnhancingU.S. Department of Health and Human Services
Waste Management & Research 39(1) DOI: 10.1177/0734242X211029175
Serie: Documentos Técnico
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f
...
Access to health workers who are fit for purpose, motivated and protected is a fundamental force of health service delivery and the achievement of universal health coverage and the health and health-related Sustainable Development Goals. Data and knowledge of the distribution, skill mix and future d
...
At the forefront of DNDi’s efforts to develop new treatments is the need to understand the realities and treatment needs of patients and health care staff in the field. The ultimate goal for human African trypanosomiasis (HAT) is a truly simplified
treatment which can be orally administered, impl
...
La sécurité du traitement hospitalier et la réalité des soins sont des
préoccupations majeures dans les systèmes de santé. La transfusion sanguine a fait l’objet de procédures juridiques et d’études
au Canada, en Angleterre, en France, en Irlande et dans d’autres
pays. Il conviendr
...
This document focuses on the management of patients affected by gambiense HAT and
constitutes an update to the WHO therapeutic guidance issued in 2013. The main changes in recommendations concern the criteria and methods for deciding the treatment among the new set of therapeutic options and the pa
...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher
...
